XML 42 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
IPO
Series A Convertible Preferred Stock
Common Stock
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2018 $ (263)         $ 1,390     $ (1,653)
Balance (in shares) at Dec. 31, 2018       4,274,734          
Issuance of common stock 1,440     $ 1   1,439      
Issuance of common stock (in shares)       4,428,500          
Net loss (1,198)               (1,198)
Balance at Dec. 31, 2019 (21)     $ 1   2,829     (2,851)
Balance (in shares) at Dec. 31, 2019       8,703,234          
Issuance of Series A convertible preferred stock, net of issuance costs of $261     $ 55,738            
Issuance of Series A convertible preferred stock, net of issuance costs of $261 (in shares)     7,064,925            
Issuance of common stock 10,192         10,192      
Issuance of common stock (in shares)       3,175,279          
Issuance of restricted stock (in shares)       74,594          
Stock-based compensation expense 322         322      
Net loss (5,324)               (5,324)
Balance at Dec. 31, 2020 5,169     $ 1   13,343     (8,175)
Balance (in shares) at Dec. 31, 2020     7,064,925            
Balance at Dec. 31, 2020     $ 55,738            
Balance (in shares) at Dec. 31, 2020       11,953,107          
Series A convertible preferred stock issuance costs     $ (3)            
Issuance of common stock   $ 152,754     $ 1   $ 152,753    
Issuance of common stock (in shares)         9,823,532        
Issuance of restricted stock (in shares)       204,187          
Conversion of Series A convertible preferred stock into common stock 55,735     $ 1   55,734      
Conversion of Series A convertible preferred stock into common stock (in shares)     (7,064,925)            
Conversion of Series A convertible preferred stock into common stock     $ (55,735)            
Conversion of Series A convertible preferred stock into common stock (in shares)       7,064,925          
Exercise of stock options $ 254         254      
Exercise of stock options, (in shares) 48,663     48,663          
Purchases under employee stock purchase plan $ 214         214      
Purchases under employee stock purchase plan (in shares)       21,007          
Stock-based compensation expense 6,234         6,234      
Unrealized gain (loss) on investments, net (10)             $ (10)  
Net loss (41,567)               (41,567)
Balance at Dec. 31, 2021 $ 178,783     $ 3   $ 228,532   $ (10) $ (49,742)
Balance (in shares) at Dec. 31, 2021     0            
Balance (in shares) at Dec. 31, 2021       29,115,421